Pharmafile Logo

Do Healthcare Providers Really Want to Go Back to In-person Meetings?

Healthcare professionals (HCPs) are increasingly seeking flexibility and convenience in their interactions with pharmaceutical and life sciences companies. This shift towards digital and blended approaches presents a valuable opportunity for life sciences organizations to enhance their communication and build stronger relationships with HCPs.

- PMLiVE

It is easy to assume that healthcare providers (HCPs) all want to go back to in-person meetings after having been confined to Zoom and Microsoft Teams meetings during the pandemic years. Anecdotally, however, we heard different things: many HCPs highlighted the convenience of the virtual format and considered this a silver lining from the long months of social and physical distancing. In a recent study by our group, the authors sought to understand this. They asked the very important question: what do HCPs really prefer when it comes to Pharma-sponsored small-group meetings such as advisory boards?

Preferred Meeting Format of HCPs

Male healthcare provider (HCP) attending a virtual meetingWhen asked about their preference for future advisory board meetings, a whopping 76% of surveyed HCPs opted for meetings with a virtual component (hybrid, real-time web, and/or asynchronous meetings). Less than a quarter of respondents preferred in-person–only meetings. Interestingly, the most popular meeting approach was found to be a mix of synchronous (real-time) and asynchronous (over-time, anytime) meetings. This finding highlights the importance of using varied formats to cater to all preferences and to avoid digital fatigue.

Another interesting finding was that the preference for hybrid meetings almost doubled between 2022 and 2023, while the preference for in-person–only meetings remained stable. In other words, while many HCPs undoubtedly do still enjoy in-person engagements, giving them the choice of how to attend will help ensure that everyone is happy…

Read the full article here.

 

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Alternative Approaches to Personalized Medicine in Oncology

Laura Towart, Founder & CEO of My Personal Therapeutics, discusses her company’s approach to precision medicine, the barriers patients with cancer face when trying to access personalized treatments, and how...

Reimagining Healthcare Using Mobile Health Technologies

Kim Shah, CEO of KnowYourMeds, explores digital health, AI, telemedicine, health literacy, and how to ensure a safe return to work amidst the ongoing COVID-19 pandemic. We also dive into...

Gene Editing and Precision Medicine: The Future of Healthcare?

Dr. Oscar Segurado, Chief Medical Officer at ASC Therapeutics, dives into advanced gene therapies, gene editing, and personalized medicine. We also explore the many different hats he wears as CMO, consultant,...

CRM Design and Optimization for Life Science Organizations

John Leombruno, CEO of OkRx, shares how his company is working to improve PSP strategy and operations in Canada. He also discusses the impact of COVID-19 on PSPs, digital transformation, clinical...

Enabling Patient-Focused Research Through Virtual Clinical Trials

Chad Walsh, CEO of Sciteline, dives into virtual trials, including their benefits, barriers, and impact on patient-centricity. Among other things, we will discuss data privacy concerns, the role of digital...

Innovative Approaches to Managing Mental Health Conditions

Owen Muir, MD, CIO at Brooklyn Minds, explores the secondary effects of COVID-19 on mental health conditions, along with techniques such as deep Transcranial Magnetic Stimulation (dTMS), Mentalization-Based Treatment (MBT), and...

Looking back at the year when everything changed

COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families.

PRESS RELEASE: IMPETUS DIGITAL LAUNCHES INSITE EVENTâ„¢

Impetus Digital launches InSite Event™ -  the most comprehensive virtual event platform for life science companies, delivered with white glove service

Risk Management, Ethics, and Compliance Considerations in the New Normal

Myriam Prescott, Head of Ethics, Risks and Compliance - Oncology, Novartis Canada, dissects the importance of effective patient engagement and strong compliance & monitoring programs. We also dive into the...

A Deep-Dive into the COVID-19 Pandemic and its Secondary Effects

Dr. Farah Fourcand, Author of Pandemic Manifesto, shares her experience working on the frontlines of the COVID-19 pandemic. She also dives into the psychological impact of COVID-19, lessons learned from the...